Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
June 14, 2016
Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments
Alex Mutebi, Marion Slack, Terri L Warholak, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 24, 2023
The economic value of knowing BRCA status: <i>BRCA</i> testing for optimizing treatment in recurrent epithelial ovarian cancer
Mok Oh, Ali McBride, Sandipan Bhattacharjee, et al.
Pain Medicine (Malden, Mass.)
|
May 3, 2020
Nationally Representative Health Care Expenditures of Community-Based Older Adults with Pain in the United States Prescribed Opioids vs Those Not Prescribed Opioids
David R Axon, Marion Slack, Leila Barraza, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 25, 2022
Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States
Neda Alrawashdh, Ali McBride, Marion Slack, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 17, 2023
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment
Mok Oh, Ali McBride, Sandipan Bhattacharjee, et al.
Frontiers in Oncology
|
March 3, 2020
Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis
Abdulaali R Almutairi, Ali McBride, Marion Slack, et al.
Therapeutic Advances in Drug Safety
|
April 2, 2021
Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER-Medicare database
Abdulaali R Almutairi, Marion Slack, Brian L Erstad, et al.
Expert Opinion on Drug Safety
|
January 15, 2021
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data
Abdulaali R Almutairi, Brian L Erstad, Ali McBride, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 13, 2023
The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention
Mok Oh, Ali McBride, Sandipan Bhattacharjee, et al.
American Journal of Pharmaceutical Education
|
November 15, 2018
Identification of Key Business and Management Skills Needed for Pharmacy Graduates
Jill Augustine, Marion Slack, Janet Cooley, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
June 14, 2016
Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments
Alex Mutebi, Marion Slack, Terri L Warholak, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 24, 2023
The economic value of knowing BRCA status: <i>BRCA</i> testing for optimizing treatment in recurrent epithelial ovarian cancer
Mok Oh, Ali McBride, Sandipan Bhattacharjee, et al.
Pain Medicine (Malden, Mass.)
|
May 3, 2020
Nationally Representative Health Care Expenditures of Community-Based Older Adults with Pain in the United States Prescribed Opioids vs Those Not Prescribed Opioids
David R Axon, Marion Slack, Leila Barraza, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 25, 2022
Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States
Neda Alrawashdh, Ali McBride, Marion Slack, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 17, 2023
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment
Mok Oh, Ali McBride, Sandipan Bhattacharjee, et al.
Frontiers in Oncology
|
March 3, 2020
Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis
Abdulaali R Almutairi, Ali McBride, Marion Slack, et al.
Therapeutic Advances in Drug Safety
|
April 2, 2021
Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER-Medicare database
Abdulaali R Almutairi, Marion Slack, Brian L Erstad, et al.
Expert Opinion on Drug Safety
|
January 15, 2021
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data
Abdulaali R Almutairi, Brian L Erstad, Ali McBride, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 13, 2023
The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention
Mok Oh, Ali McBride, Sandipan Bhattacharjee, et al.
American Journal of Pharmaceutical Education
|
November 15, 2018
Identification of Key Business and Management Skills Needed for Pharmacy Graduates
Jill Augustine, Marion Slack, Janet Cooley, et al.
Page
of 5